ABSTRACT

1. ABSTRACT POST-OPERATIVE SECOND SURGERY • This report concerned a young patient with growing teratoma syndrome who required complete resection. • Residual disease is the commonest suspicion following fertility conserving surgery for immature teratoma of ovary in a young woman. • Administration of adjuvant chemotherapy is the usual course pathway for management of residual disease. • An enlarging intraperitoneal mass despite course of chemotherapy is usually due to treatment failure but rarely may be as a result of growing teratoma syndrome. • Complete resection is essential to prevent progression of tumour and is often curative, hence, will render better prognosis as mature teratoma are resistant to both chemotherapy and radiotherapy. DISCUSSION CHEMOTHERAPY CASE PRESENTATION INTRA-OPERATIVE FINDINGS FOLLOW-UP FIGO stage 1a GROWING TERATOMA SYNDROME IS SUSPECTED SECOND SURGERY REFERENCES Logothetis CJ, Samuels ML, Trindade A, Johnson DE. The growing teratoma syndrome. cancer 1982;50:1629-35. DiSaia PJ, Saltz A, Kagan AR, Morrow CP. Chemotherapeutic retroconversion of immature teratoma of the ovary. Obstet Gynecol. 1977;49(3):346– 50. Inaoka T, Takahashi K, Yamada T, Miyokawa N, Tokusashi Y, Yoshida M, Sugimoto M, Miyamoto K, Aburano T. The growing teratoma syndrome secondary to immature teratoma of the ovary.EurRadiol. 2003 Sep;13(9):2115-8. Nimkin K, Gupta P, McCauley R, Gilchrist BF, Lessin MS. The growing teratoma syndrome.PediatrRadiol. 2004 Mar;34(3):259-62.